Effect of bevacizumab against cystic components of brain tumors

BACKGROUND: Bevacizumab improves symptoms via reducing the peritumoral edema and/or normalizing blood brain barrier, and occasionally via reducing the tumor size. However, the effect against active cystic components has not been documented yet. MATERIALS AND METHODS: Between 2008 and 2018, 139 patie...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer Med
Hauptverfasser: Yamasaki, Fumiyuki, Kolakshyapati, Manish, Takano, Motoki, Yonezawa, Ushio, Nishibuchi, Ikuno, Imano, Nobuki, Taguchi, Akira, Onishi, Shumpei, Amatya, Vishwa Jeet, Takeshima, Yukio, Nagata, Yasushi, Kurisu, Kaoru, Sugiyama, Kazuhiko
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2019
Schlagworte:
Clinical Cancer Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6825995/
https://ncbi.nlm.nih.gov/pubmed/31498567
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2537
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge